Development and current status of related clinical trials
cancer, cervical cancer, NCT00002506
CANCER, CERVICAL CANCER, RECURRENT CANCER
Through the analysis of clinical trials, it was found that the attempts of immunotherapies in cervical cancer started in 1992 (a clinical trial using Isotretinoin plus Interferon to treat patients with recurrent cancer (NCT00002506)). During the next 25 years, the development of immunotherapies for cervical cancer kept a slow pace. And over the past five years, lots of changes have occurred since the remarkable effect of immune checkpoint blockades on cervical cancer was represented. Both the scientometric analysis (
The phases of clinical trials (All the related clinical trials in Phase III (or Phase II/III).r/m means recurrent or metastatic, and LA means locally advanced.* means clinical trials are Phase II|Phase III.The cancer stages for cervical cancer in clinical trials (